XML 79 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) before Income Taxes
The U.S. and foreign components of income before income taxes were as follows:
Years Ended December 31,
(in millions)202320222021
U.S.$199.5 $11.8 $25.3 
Foreign15.1 (2.0)(4.8)
Income before income taxes$214.6 $9.8 $20.5 
Schedule of Income Tax Expense
Income tax expense consists of the following: 
Years Ended December 31,
(in millions)202320222021
Current:
U.S. State$3.7 $1.3 $0.5 
Foreign4.1 4.8 2.0 
Total current tax expense
7.8 6.1 2.5 
Deferred:
U.S. Federal0.1 — — 
Foreign0.4 (0.9)1.2 
Total deferred tax expense (benefit)
0.5 (0.9)1.2 
Total income tax expense$8.3 $5.2 $3.7 
Schedule of Reconciliations of the Federal Statutory Rate
Reconciliations of the U.S. federal statutory rate to the Company’s effective tax rate are as follows:
 Years Ended December 31,
 202320222021
U.S. statutory rate21.0 %21.0 %21.0 %
Foreign rate differential0.6 13.2 4.8 
State taxes, net of federal benefit2.4 (5.0)(9.5)
Federal and state R&D credits
(5.9)(49.4)(26.2)
Stock-based compensation(3.2)(94.8)(117.0)
Extinguishment of debt— — (57.5)
Capital loss carryforward expirations— — 52.1 
Non-deductible officers’ compensation1.3 52.4 45.7 
Permanent items0.7 6.3 1.9 
Foreign income taxed in the U.S.0.7 14.5 — 
Change in valuation allowance(10.8)124.4 97.9 
Tax rate changes0.5 (30.9)— 
Change to prior year R&D credit
(2.8)— — 
Intercompany transfer of intellectual property— — 4.6 
Other(0.6)1.7 0.4 
Effective tax rate3.9 %53.4 %18.2 %
Schedule of Unrecognized Tax Benefits Roll Forward
The following table summarizes the activity related to the Company’s unrecognized tax benefits:
(in millions)
Unrecognized tax benefits at December 31, 2022$— 
Additions related to current period tax positions
2.6 
Additions related to prior period tax positions
2.4 
Unrecognized tax benefits at December 31, 2023
$5.0 
Schedule of Company's Deferred Tax Assets (Liabilities)
The components of the net deferred tax asset at the end of each year consist of the following:
 As of December 31,
(in millions)20232022
Deferred tax assets:
Net operating loss carryforwards$91.4 $143.5 
Tax credits54.1 33.6 
Capitalized research and development expenditures53.3 30.4 
Warranty2.2 14.6 
Accrued expenses22.9 10.2 
Amortization of debt discount7.8 11.0 
Inventory capitalization6.5 4.1 
Intangible assets8.0 12.9 
Interest limitation carryforwards— 1.7 
Incentive compensation13.5 9.4 
Stock-based compensation8.0 6.4 
Other5.4 4.5 
Total deferred tax assets273.1 282.3 
Deferred tax liabilities:
Prepaid assets(7.7)(5.3)
Property, plant and equipment(38.1)(31.5)
Capitalized contract acquisition costs(10.4)(10.4)
Unrealized gains on cash flow hedges(5.1)(8.8)
Other(7.7)(1.9)
Total deferred tax liabilities(69.0)(57.9)
Net deferred tax asset before valuation allowance204.1 224.4 
Valuation allowance(202.9)(222.8)
Net deferred tax asset$1.2 $1.6 
Schedule of Net Operating Loss and Tax Credit Carryforwards
As of December 31, 2023, the Company’s net operating loss carryforwards were as follows:
(in millions)
Expiration Period
Net Operating Loss Carryforwards
U.S. federal
Indefinite
$192.0 
U.S. federal
2032 - 2037
$150.2 
State
2024 - 2042
$238.3 
Foreign
Indefinite
$23.2 
As of December 31, 2023, the Company’s tax credit carryforwards were as follows:
(in millions)
Expiration Period
Tax Credit Carryforwards
U.S. federal
2024 - 2043$40.1 
State2024 - 2043$23.6